SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Comment Letter for Edgemode, (EDGM) — Apr 13, 2021

Edgemode, Inc.
Date: April 13, 2021 · CIK: 0001652958 · Accession: 0000000000-21-004431

AI Filing Summary & Sentiment

File numbers found in text: 333-255168

Date
April 13, 2021
Author
Not clearly detected
Form
UPLOAD
Company
Edgemode, Inc.

Letter

United States securities and exchange commission logo April 13, 2021 J. Jacob Isaacs Chief Executive Officer Fourth Wave Energy, Inc. 75 E. Santa Clara St., 6th Floor San Jose, CA 95113 Re:Fourth Wave Energy, Inc. Registration Statement on Form S-1 Filed April 9, 2021 File No. 333-255168 Dear Mr. Isaacs: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact David Gessert at 202-551-2326 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text
United States securities and exchange commission logo
April 13, 2021
J. Jacob Isaacs
Chief Executive Officer
Fourth Wave Energy, Inc.
75 E. Santa Clara St., 6th Floor
San Jose, CA 95113
Re:Fourth Wave Energy, Inc.
Registration Statement on Form S-1
Filed April 9, 2021
File No. 333-255168
Dear Mr. Isaacs:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact David Gessert at 202-551-2326 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences